The Priority Review

Tag

cobas eplex respiratory pathogen panel 3

1 story

  1. Regulation

    Roche receives FDA 510(k) clearance for new cobas eplex respiratory pathogen panel 3

    Roche announced the FDA 510(k) clearance of the cobas eplex respiratory pathogen panel 3 (RP3), a flexible syndromic test that detects up to 19 viral and bacterial targets from a single nasopharyngeal swab. The panel offers up to five customizable configurations, requires less than one minute of hands-on time, and delivers results in under two hours.